NO20090348L - Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme - Google Patents
Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av sammeInfo
- Publication number
- NO20090348L NO20090348L NO20090348A NO20090348A NO20090348L NO 20090348 L NO20090348 L NO 20090348L NO 20090348 A NO20090348 A NO 20090348A NO 20090348 A NO20090348 A NO 20090348A NO 20090348 L NO20090348 L NO 20090348L
- Authority
- NO
- Norway
- Prior art keywords
- processes
- compositions
- preparation
- well
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det beskrives polysubstituerte imidazolonderivater, farmasøytiske sammensetninger inneholdende disse og terapeutiske anvendelser derav innen feltene helse for mennesker og dyr. Det beskrives også prosesser for å fremstille disse derivater. 5
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0606752A FR2903984B1 (fr) | 2006-07-24 | 2006-07-24 | Derives d'imidazolones substitues, preparation et utilisations |
PCT/FR2007/051716 WO2008012470A2 (fr) | 2006-07-24 | 2007-07-24 | Derives d'imidazolones substitues, preparation et utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090348L true NO20090348L (no) | 2009-04-24 |
Family
ID=37843186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090348A NO20090348L (no) | 2006-07-24 | 2009-01-22 | Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme |
Country Status (16)
Country | Link |
---|---|
US (1) | US20100004159A1 (no) |
EP (1) | EP2049107A2 (no) |
JP (1) | JP2009544675A (no) |
KR (1) | KR20090038469A (no) |
CN (1) | CN101522192A (no) |
AU (1) | AU2007279135A1 (no) |
BR (1) | BRPI0715326A2 (no) |
CA (1) | CA2658625A1 (no) |
EA (1) | EA200900211A1 (no) |
FR (1) | FR2903984B1 (no) |
IL (1) | IL196671A0 (no) |
MX (1) | MX2009000900A (no) |
NO (1) | NO20090348L (no) |
NZ (1) | NZ575011A (no) |
WO (1) | WO2008012470A2 (no) |
ZA (1) | ZA200901268B (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011119541A1 (en) * | 2010-03-26 | 2011-09-29 | Schering Corporation | Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
US8633231B2 (en) | 2010-07-13 | 2014-01-21 | Merck Sharp & Dohme Corp. | Substituted imidazolones, compositions containing such compounds and methods of use |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP3628661A1 (en) * | 2013-06-27 | 2020-04-01 | Lg Chem, Ltd. | Biaryl derivatives as gpr120 agonists |
EP3083600B1 (en) | 2013-12-17 | 2018-09-26 | Janssen Pharmaceutica NV | Imidazolin-5-one derivatives useful as fasn inhibitors for the treatment of cancer |
CN105439946B (zh) * | 2014-08-13 | 2018-02-02 | 益方生物科技(上海)有限公司 | 羧酸化合物及其制备方法和用途 |
CN104177298B (zh) * | 2014-09-18 | 2018-10-02 | 湘潭大学 | 4,4-二取代-4,5-二氢-1h–咪唑-5-酮、衍生物及其合成方法 |
JP7000321B2 (ja) | 2015-07-17 | 2022-02-10 | アンスティテュ・パストゥール | 衛星細胞の自己再生および/または分化の促進剤としての使用のための5-ヒドロキシトリプタミン1b受容体刺激剤 |
WO2017043092A1 (en) * | 2015-09-11 | 2017-03-16 | Raqualia Pharma Inc. | Imidazolinone derivatives as trpm8 antagonists |
ES2823190T3 (es) | 2016-03-31 | 2021-05-06 | Oncternal Therapeutics Inc | Análogos de indolina y usos de los mismos |
CN110022869A (zh) | 2016-07-15 | 2019-07-16 | 巴斯德研究院 | 用于皮肤和/或毛发修复的5-羟色胺1b受体刺激剂 |
CN113121394B (zh) * | 2019-12-30 | 2022-11-08 | 中国药科大学 | 一种苯氧乙酸类衍生物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005517643A (ja) * | 2001-11-30 | 2005-06-16 | イーライ・リリー・アンド・カンパニー | ペルオキシソーム増殖因子活性化受容体アゴニスト |
US7232828B2 (en) * | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
US20050020654A1 (en) * | 2003-03-15 | 2005-01-27 | Pershadsingh Harrihar A. | Novel PPAR agonists, pharmaceutical compositions and uses thereof |
-
2006
- 2006-07-24 FR FR0606752A patent/FR2903984B1/fr not_active Expired - Fee Related
-
2007
- 2007-07-24 CA CA002658625A patent/CA2658625A1/fr not_active Abandoned
- 2007-07-24 EA EA200900211A patent/EA200900211A1/ru unknown
- 2007-07-24 MX MX2009000900A patent/MX2009000900A/es active IP Right Grant
- 2007-07-24 US US12/309,642 patent/US20100004159A1/en not_active Abandoned
- 2007-07-24 JP JP2009521318A patent/JP2009544675A/ja active Pending
- 2007-07-24 NZ NZ575011A patent/NZ575011A/en not_active IP Right Cessation
- 2007-07-24 AU AU2007279135A patent/AU2007279135A1/en not_active Abandoned
- 2007-07-24 BR BRPI0715326-0A patent/BRPI0715326A2/pt not_active IP Right Cessation
- 2007-07-24 WO PCT/FR2007/051716 patent/WO2008012470A2/fr active Application Filing
- 2007-07-24 CN CNA2007800352070A patent/CN101522192A/zh active Pending
- 2007-07-24 EP EP07823633A patent/EP2049107A2/fr not_active Withdrawn
- 2007-07-24 KR KR1020097003832A patent/KR20090038469A/ko not_active Application Discontinuation
-
2009
- 2009-01-22 IL IL196671A patent/IL196671A0/en unknown
- 2009-01-22 NO NO20090348A patent/NO20090348L/no not_active Application Discontinuation
- 2009-02-23 ZA ZA200901268A patent/ZA200901268B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007279135A1 (en) | 2008-01-31 |
ZA200901268B (en) | 2010-04-28 |
CN101522192A (zh) | 2009-09-02 |
EP2049107A2 (fr) | 2009-04-22 |
KR20090038469A (ko) | 2009-04-20 |
IL196671A0 (en) | 2009-11-18 |
FR2903984A1 (fr) | 2008-01-25 |
US20100004159A1 (en) | 2010-01-07 |
WO2008012470A2 (fr) | 2008-01-31 |
WO2008012470A3 (fr) | 2008-03-20 |
FR2903984B1 (fr) | 2008-10-03 |
JP2009544675A (ja) | 2009-12-17 |
BRPI0715326A2 (pt) | 2013-08-13 |
EA200900211A1 (ru) | 2009-06-30 |
MX2009000900A (es) | 2009-06-18 |
CA2658625A1 (fr) | 2008-01-31 |
NZ575011A (en) | 2011-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090348L (no) | Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme | |
NO20085338L (no) | Substituerte 1,3-difenylpropanderivater, sammensetninger og anvendelser derav | |
NO20083153L (no) | Kjemiske forbindelser | |
ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
WO2007118963A3 (fr) | Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations | |
WO2008087367A3 (fr) | Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations | |
CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
IL204732A (en) | @@@@@ - Diplooro - @@ - Deoxy @ tetrahydro uridines, preparations containing them and their use in making @ drugs | |
DK2026803T3 (da) | Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf | |
NO20084362L (no) | Difenylazetidinon derivater inneholdende kolesterol absorbsjonsinhibitor aktivitet | |
MX2008007307A (es) | Granulos/capsulas modificados que contienen ingrediente activo. | |
WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
UA100007C2 (ru) | Гетероциклические ингибиторы мек, их применение и фармацевтическая композиция, которая их содержит | |
ATE350409T1 (de) | Ampholytisches copolymer und dessen verwendung | |
MA31231B1 (fr) | Anticorps anti-robo4 et utilisations de ceux-ci | |
SE0401971D0 (sv) | Piperidne derivatives | |
MX2009007337A (es) | Indazoles sustituidos con 5-piridinona. | |
MY162640A (en) | Thioninium compounds and their use | |
EA200601288A1 (ru) | Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение | |
WO2008087365A3 (fr) | Derives de 1,3-diphenylpropane substitues, preparations et utilisations | |
MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
WO2008087366A3 (fr) | Derives de 3-phenyl-1-(phenylthienyl)propan-1-one et de 3-phenyl-1-(phenylfuranyl)propan-1-one substitues, preparation et utilisation | |
MY150098A (en) | Benzylpiperazine derivates and their medical use | |
UY29999A1 (es) | "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones" | |
DE602005019722D1 (de) | Substituierte pyrrolidin-2-one |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |